Key Findings:  Summary of a plan to review the existing literature about medicinal cannabis in children and adolescents with autism spectrum disorder to explore symptoms, adverse events, and outcomes.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  Canada
Year of Pub:  2021
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable
Citation:  Fletcher S, et al. Symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol. JBI Evid Synth. 2021; 19:1251-1258. doi: 10.11124/JBIES-20-00001
Authors:  Fletcher S, Pawliuk C, Ip A, Oberlander T, Siden H